Where are the RNA vaccines for TB?
A simple mRNA vaccine was shown to protect mice against tuberculosis more than 15 years ago. Like COVID-19, tuberculosis is a respiratory infection killing over a million people per year. It too presents a global emergency. Can the stunning success of RNA vaccination against COVID-19 be replicated for TB?.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Emerging Microbes and Infections - 10(2021), 1, Seite 1217-1218 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Xiao-Yong Fan [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
COVID-19 |
|---|
| doi: |
10.1080/22221751.2021.1935328 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ01795083X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ01795083X | ||
| 003 | DE-627 | ||
| 005 | 20230310093737.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/22221751.2021.1935328 |2 doi | |
| 035 | |a (DE-627)DOAJ01795083X | ||
| 035 | |a (DE-599)DOAJ87c58bdc0b5a48f5a4606ea22eeba5e6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC109-216 | |
| 050 | 0 | |a QR1-502 | |
| 100 | 0 | |a Xiao-Yong Fan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Where are the RNA vaccines for TB? |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a A simple mRNA vaccine was shown to protect mice against tuberculosis more than 15 years ago. Like COVID-19, tuberculosis is a respiratory infection killing over a million people per year. It too presents a global emergency. Can the stunning success of RNA vaccination against COVID-19 be replicated for TB? | ||
| 650 | 4 | |a Tuberculosis | |
| 650 | 4 | |a RNA vaccination | |
| 650 | 4 | |a vaccine | |
| 650 | 4 | |a in vitro transcription | |
| 650 | 4 | |a COVID-19 | |
| 653 | 0 | |a Infectious and parasitic diseases | |
| 653 | 0 | |a Microbiology | |
| 700 | 0 | |a Douglas Bruce Lowrie |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Emerging Microbes and Infections |d Taylor & Francis Group, 2013 |g 10(2021), 1, Seite 1217-1218 |w (DE-627)DOAJ00011538X |x 22221751 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2021 |g number:1 |g pages:1217-1218 |
| 856 | 4 | 0 | |u https://doi.org/10.1080/22221751.2021.1935328 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/87c58bdc0b5a48f5a4606ea22eeba5e6 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.tandfonline.com/doi/10.1080/22221751.2021.1935328 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2222-1751 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2021 |e 1 |h 1217-1218 | ||